Super NootrOpa is the subject of 16 published scientific studies confirming efficacy.
What is Super NootrOPa?
Super NootrOpa is a patented, clinically proven natural botanical nootropic ingredient that improves memory, concentration and learning ability. This ingredient is developed through 50 years of extensive research.
Super NootrOpa is the only clinically proven natural botanical ingredient to improve memory, attention, and focus in adults and children. Gold-standard scientific research has established the clinical efficacies of Super NootrOpa.
The Nootropic benefits of Super NootrOpa are demonstrated by 16 published scientific papers consisting of nine randomized human clinical studies, six pre-clinical studies and one meta-analysis conducted across age groups ranging from 06 to 65 years. A single dose of Super NootrOpa, either 320 mg or 640 mg, improves multi-tasking, visual attention, mood, and stress reduction compared to a placebo.
Super NootrOpa quickly improved the speed of continuous performance and visual information processing, reducing stress and mental fatigue just after 2 hours of supplementation.
Super NootrOpa at 125mg/day significantly improved cognitive control, logical memory, working memory, and paired associated learning.
Super NootrOpa improved accuracy, reaction time, problem-solving ability, executive function, and sleep routine in hyperactive and inattentive boys aged 6 to 14.
Super NootrOpa prevents neurochemical alterations in the brain by normalizing the ratio of two NMDAR subunits (NR2A and NR2B) and their downstream mediators (7, 8). Super NootrOpa improves short-term memory and elevates mood by modulating the combined action of serotonergic and cholinergic systems.
Super NootrOpa enhances memory retention via upregulation of Fmr-1 Gene expression. Super NootrOpa acts as an adaptogen by reversing the biochemical changes induced by acute and chronic stressors.
Applications
The Nootropic benefits of Super NootrOpa are demonstrated by 15 published scientific papers consisting of nine randomized human clinical studies, six pre-clinical studies and one meta-analysis conducted across the age groups ranging from 6 to 65 years.
Super NootrOpa modulates antioxidant activity and enhances the defense against free radicals induced damage.
Super NootrOpa increases SOD, CAT and GPx activities in the frontal cortex, striatum and hippocampus in rats.
Super NootrOpa 300 mg/day for 12 weeks significantly improved
Super NootrOpa (300 mg/90 days) significantly
Super NootrOpa (125 mg/twice a day) to subjects (age: 55-70 Y) with age associated memory impairment (AAMI)’ significantly
Super NootrOpa (300 mg/day) for 90 days significantly
Single dose (either 320 or 640 mg) of Super NootrOpa showed
Single dose of Super NootrOpa (320 & 640 mg) shows
Super NootrOpa 160 & 320 mg showed significant improvements in
Significant improvements in
Clinical study in young children
Observation:
Spatial working memory significantly improved in school going children (7-12 years)
This was a randomized, double-blind, parallel design trial
Clinical study in Aged population
Observation:
Elderly (>65 years) participants improved cognition, decreased anxiety and depression.7
Randomized, double-blind and placebo-controlled study, Significant improvements in
Acute oral toxicity studies have shown doses up to 5000mg/kg did not show any significant health effects.6
The B. monnieri extract at a dose of 1500mg/kg for 270 days did not show any abnormalities.6
Learning & Memory:
The Food and Drug Administration has not evaluated statements on this website. The products are not intended to diagnose, treat, cure or prevent disease. This website’s technical content and claims are for business information purposes only. Your legal counsel should review them before use in marketing materials, including product labels. Some of these statements may not apply to your markets or regulations since they are intended for various geographies worldwide.